top of page
The latest on cardiometabolic disease and Covid-19
Search
Abderrahim Benmoussa, phD
Apr 7, 20202 min read
Experimental treatments and controversies, a review
Quality of evidence: C Controversial treatments: an updated understanding of the Coronavirus Disease 2019 Authors: Zhang C et al Journal:...
31 views0 comments
Abderrahim Benmoussa, phD
Apr 7, 20201 min read
Heparin and mortality in patients with coagulopathy, a retrospective cohort study
Quality of evidence: B- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with...
4 views0 comments
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Early use of short term corticosteroids therapy, an open-label non-randomized monocentric trial
Quality of evidence: C- Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19...
4 views0 comments
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Anti-inflammatory drugs and severe cases, a review, and expert position from China
Quality of evidence: C+ The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19):...
4 views0 comments
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Management of critically ill adults, a guideline summary for practioners
Quality of evidence: B- Management of Critically Ill Adults With COVID-19 Authors: Poston JT et al. Journal: JAMA Objectives: Centralize...
7 views0 comments
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
Treatment of COVID-19-induced myocarditis in a young adult, a case report
Quality of evidence: D Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin Authors: Hu H et al Journal: ...
5 views0 comments
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
QT and Hydroxychloroquine/Azithromycin, a retrospective cohort study
Strength of evidence: C+ The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin Authors:...
29 views0 comments
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
Danger of Angiotensin receptor-blockers ? A letter to the editor
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
21 views0 comments
bottom of page